International Journal of Antimicrobial Agents

Article	Citations
Title Page & Editorial Board	82
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	64
Cystathionine γ-lyase: The Achilles heel of bacterial defense systems	60
A contribution on the fosfomycin mechanism of resistance in multidrug-resistant organisms	57
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole gen	56
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	52
Daily fluid intake as a novel covariate affecting the population pharmacokinetics of polymyxin B in patients with sepsis	50
Erratum to “Empiric antibiotic protocols for cancer patients with neutropenia: a single–center study of treatment efficacy and mortality in patients with bacteremia” [International Journal of Antimicr	49
The New Delhi metallo-β-lactamase-1 biosensor rapidly and accurately detected antibiotic plasma concentrations in cefuroxime-treated patients	48
Large-scale comparative analysis reveals phylogenomic preference of blaNDM-1 and blaKPC-2 transmission among Klebsiella pneumoniae	48
Title Page & Editorial Board	47
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	45
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	44
Heterogeneous Vancomycin Intermediate Staphylococcus aureus infections in tertiary care hospitals in Coastal Karnataka, India	43
Mycobacterium species on the cutaneous microbiome of very preterm neonates admitted to the NICU in a tertiary health care hospital	42
Antimicrobial therapy for carbapenem-resistant gram-negative bacteria	37
Emergence of intrinsically resistant Gram-negative bacteria with an environmental primary habitat	37
Vaccines against SARS-COV-2	36
In vitro activity of β-lactam-β-lactam enhancer combination, cefepime/zidebactam (WCK 5222, FEP/ZID) against multi-clonal, colistin-resistant Klebsiella pneumoniae	36
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	34
Severe Salmonella enteritidis infection complicated with colonic perforations and abdominal cocoon	34
Effectiveness of rifampicin combination therapy for orthopaedic implant-related infections: A systematic review and meta-analysis	34
Hospitalization decision model for COVID-19 patients with comorbidities	34
Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia	33
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	33

Antifungal activity and potential mechanism of action of caspofungin in combination with ribavirin against Candida albicans	32
Global prevalence of fosfomycin resistance genes fosA and fosB in multidrug-resistant bacteria	32
Dysbiosis of the gut microbiota is associated with in-hospital mortality in patients with antibiotic-associated diarrhoea: A metagenomic analysis	32
Colistin- and tigecycline-resistant CTX-M-14-producing Salmonella enterica serovar Kentucky ST198 from retail chicken meat, China	31
Efficacy of clofazimine-containing regimens for treatment of Mycobacterium avium complex–pulmonary disease in patients unsuitable for standard treatment regimen	30
Development of a new antibiotic-induced dysbiosis model of the canine colonic microbiota	30
Immunomodulator AS101 restores colistin susceptibility of clinical colistin-resistant Escherichia coli and Klebsiella pneumoniae in vitro and in vivo	30
Daptomycin non-susceptible Staphylococcus argenteus isolated from a patient without prior antibiotic exposure	30
A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting	28
Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy	28
Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis	27
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university ho	27
Antibiotic resistance in Enterobacter hormaechei	27
Antibiotic spectrum index as an antimicrobial stewardship tool in paediatric intensive care settings	27
Machine learning accelerates the discovery of epitope-based dual-bioactive peptides against skin infections	27
How I treat CMV infection in high-risk pediatric patients?	25
Extended infusion improves meropenem and piperacillin/tazobactam effectiveness in septic burn patients with normal renal by applying pharmacokinetics-pharmacodynamics approach	24
Cross-talk between signal transduction systems and metabolic networks in antibiotic resistance and tolerance	24
Psychological effects of paramedics by experience of managing COVID-19 patients	24
Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study	24
Resistance profiling and molecular characterization of methicillin-resistant Staphylococcus pseudintermedius isolated from dogs and cats	24
Demography and antibiotic susceptibility of emerging Chryseobacterium gleum among hospitalised patients in Malaysia	24
Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae	24
Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant	23
Global evolutionary dynamics of virulence genes in ST11-KL47 carbapenem-resistant Klebsiella pneumoniae	23
Variability in oral antibiotic step-down therapy in the management of Gram-negative bloodstream infections	23
Systematic review and meta-analysis to explore optimal therapeutic range of vancomycin trough level for infected paediatric patients with Gram-positive pathogens to reduce mortality and nephrotoxicity	22
Detection of mcr-1-harbouring Escherichia coli by quantum dot labelling of synthetic small peptides mimicking lipopolysaccharide receptors	22
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	21
Characterization of the extended substrate spectrum of the class A β-lactamase CESS-1 from Stenotrophomonas sp. and structure-based investigation into its substrate preference	21
In reply to the Letter to the Editor regarding Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical Gram-negative bacillary meningitis or ventriculitis: A systematic review and	21
Efficacy of combination therapy with standard-dose carbapenem for treating nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii in intensive care units: A multicentre retrospect	21
Metagenomic next-generation sequencing on treatment strategies and prognosis of patients with lower respiratory tract infections: A systematic review and meta-analysis	21
Silent dissemination of fosfomycin resistance genes in critical-priority Klebsiella pneumoniae	21
Proguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii	20
Impact of pre‐existent drug resistance on virological efficacy of single‐tablet regimens in people living with HIV	20
Microdialysis sampling to monitor target-site vancomycin concentrations in septic infants: a feasible way to close the knowledge gap	20
Effectiveness of mRNA BNT162b2 and inactivated CoronaVac vaccines against severe COVID-19 outcomes among non-hospitalised children aged 1-3 years with SARS-CoV-2 Omicron infection	20
In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam:	20
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci	20
Population pharmacokinetics of levornidazole in healthy subjects and patients, and sequential dosing regimen proposal using pharmacokinetic/pharmacodynamic analysis	20
Aerosolized plus intravenous polymyxin B in comparison to intravenous polymyxin B alone for the management of HAP caused by carbapenem-resistant gram-negative bacteria: A prospective multicenter cohor	19
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance	19
Comparing outcomes among outpatients treated for pyelonephritis with oral cephalosporins versus first-line agents	19
Alterins, a new family of marine antibacterial cyclolipopeptides	19
A Systematic Review of the Pharmacokinetics and Pharmacodynamics of Novel Beta-Lactams and Beta-Lactam with Beta-Lactamase Inhibitor Combinations for the Treatment of Pneumonia Caused by Carbapenem-Re	19
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases	19
Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients	18
PROGRAM-AT-A-GLANCE	18
Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice	18

MRSA surveillance programmes worldwide: moving towards a harmonised international approach	18
Temocillin versus carbapenems for urinary tract infection due to ESBL-producing Enterobacteriaceae: a multicenter matched case-control study	18
Eczematous skin colonization pattern with potential bacterial pathogens in paediatric population at a tertiary care setting, in Sri Lanka	18
Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-ce	18
Zidovudine in synergistic combination with fosfomycin: an in vitro and in vivo evaluation against multidrug-resistant Enterobacterales	18
Title Page & Editorial Board	18
Antimicrobial susceptibility and co-resistance among Pseudomonas aeruginosa isolates from hospital-acquired respiratory-tract infections: SMART 2017–2019 Malaysia	18
Clinical and laboratory insights into the threat of hypervirulent Klebsiella pneumoniae	18
Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel	17
High diversity of blaNDM-1-encoding plasmids in Klebsiella pneumoniae isolated from neonates in a Vietnamese hospital	17
The surveillance of colistin resistance and mobilized colistin resistance genes in multidrug-resistant Enterobacteriaceae isolated in Japan	17
Title Page & Editorial Board	17
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing	17
Longitudinal fluctuations of common antimicrobial resistance genes in the gut microbiomes of healthy Dutch individuals	17
Verapamil enhances the activity of Caspofungin against Cryptococcus neoformans， coinciding with inhibited Ca2+/CN pathway and damage to cell wall integrity	17
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based	17
High concentrations of nirmatrelvir/ritonavir in critically ill patients receiving continuous renal replacement therapy	17
Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus	17
Genomic characterization of vancomycin-resistant Enterococcus faecium transmission in hospital by whole genome sequencing	17
Colistin resistance genes mcr-1 to mcr-5, including a case of triple occurrence (mcr-1, -3 and -5), in Escherichia coli isolates from faeces of healthy pigs, cattle and poultry in Belgium, 2012–2016	17
Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes.	17
Title Page & Editorial Board	17
Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 study	17
Study on antibiotic resistance of Staphylococcus aureus isolated in Hue University hospital in 2018 and 2019	17
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	16
Shifting trends in bloodstream infection-causing microorganisms and their clinical impact in patients with haematologic malignancies in South Korea: A propensity score-matched study	16
Intrapulmonary pharmacokinetics of high doses of tigecycline in patients with ventilator-associated pneumonia	16
Corrigendum to “Clinical and Economic Evaluation of Blood Culture Whole Process Optimisation in Critically Ill Adult Patients With Positive Blood Cultures” [International Journal of Antimicrobial Agen	16
Toxoplasma gondii infection or acute retinal necrosis in early stage: A case report	16
Isavuconazole dosing in Asian patients with invasive mould infections: is there a role for therapeutic drug monitoring?	16
Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy	16
Title Page & Editorial Board	16
Molecular investigation of an epidemic dissemination of vancomycin-resistant Enterococcus faecium sequence type 80 in Guangdong province, China	16
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	16
Global distribution of blaCMY-42, a gene mediating reduced susceptibility to aztreonam-avibactam and ceftazidime-avibactam, in Escherichia coli	16
Clinical outcomes of rifampicin combination therapy in implant-associated infections due to staphylococci and streptococci: A systematic review and meta-analysis	15
Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelines	15
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	15
Beware of resistance to 2nd-generation integrase inhibitors: A systematic meta-analysis of HIV-1 integrase inhibitors resistance and drug resistance mutations	15
Novel active Trp- and Arg-rich antimicrobial peptides with high solubility and low red blood cell toxicity designed using machine learning tools	15
The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)	15
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	15
NDM-5-producing carbapenem-resistant Klebsiella pneumoniae of sequence type 789 emerged as a threat for neonates: a multicentre, genome-based study	15
Mechanisms and fitness of ceftazidime/avibactam-resistant Klebsiella pneumoniae clinical strains in Taiwan	15
Corrigendum to “Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and	15
Clinical efficacy of ceftazidime/avibactam combination therapy for severe hospital-acquired pulmonary infections caused by carbapenem-resistant and difficult-to-treat Pseudomonas aeruginosa	14
Nafcillin Augmentation of Daptomycin and Cathelicidin LL-37 Killing of Methicillin-resistant Staphylococcus epidermidis: Foundations of Successful Therapy of Endocarditis	14
What we learned from COVID-19 vaccination	14
Characteristic of Stenotrophomonas maltophilia antimicrobial profile in Malaysian isolates 2015–2020	14
Evaluation of tetracycline and fluoroquinolone therapy against Japanese spotted fever: Analysis based on individual data from case reports and case series	14
High-level delafloxacin resistance through the combination of two different mechanisms in Staphylococcus aureus	14
Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: A real-world, retrospective cohort study	14
Tracking emergence and outbreak of Klebsiella pneumoniae co-producing NDM-1 and KPC-2 after sulfamethoxazole-trimethoprim treatment: Insights from genetic analysis	14
In-silico identification of novel inhibitors for glutamate racemase (MurI) to decipher the subtle of antimicrobial resistance in Neisseria gonorrhoeae: A virtual screening and molecular dynamics appro	14
Title Page & Editorial Board	14
High-throughput mutagenesis and screening approach for the identification of drug-resistant mutations in the rifampicin resistance-determining region of mycobacteria	14
In-vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial	14
Risk of Clostridioides difficile infection following different antibiotics: insights from multi-source medical data	14
A case of atypical hemolytic uremic syndrome caused by Escherichia fergusonii mimicking Escherichia coli in an immunocompetent adult	14
Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii	14
Evaluation of synergistic activity of fosfomycin in combination with novel ß-lactams/ß-lactamase inhibitor combinations (βL-βLICs) against KPC-producing Klebsiella pneumoniae clinical isolates	14
Pleural penetration of amoxicillin and metronidazole during pleural infection: An ambispective cohort study	14
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover cli	13
Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient	13
Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies	13
Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion	13
Renal function and its impact on the concentration of ceftazidime-avibactam: A cross-sectional study	13
Functional characterization and clinical implication of a novel epidemic carbapenem-resistant Acinetobacter baumannii genetic marker	13
Disruption of biofilms and killing of Burkholderia cenocepacia from cystic fibrosis lung using an antioxidant-antibiotic combination therapy	13
Pharmacodynamics of ceftriaxone for the treatment of methicillin‐susceptible Staphylococcus aureus: is it a viable treatment option?	13
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantification	13
Human tissue distribution of caspofungin	13
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain	13
High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial	13
Ferric chloride induces ferroptosis in Pseudomonas aeruginosa and heals wound infection in a mouse model	13
Safety of high loading doses of teicoplanin: POSY-TEICO, a prospective, multicentre, observational study	13
High prevalence of clonally related ST182 NDM-1-producing Enterobacter cloacae complex clinical isolates in Greece	13
Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals	13
BPI23-Fcγ alleviates lethal multi-drug-resistant Acinetobacter baumannii infection by enhancing bactericidal activity and orchestrating neutrophil function	13
Respiratory fluoroquinolone monotherapy for community-acquired pneumonia: a revised trial sequential analysis	13

REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI	13
Pharmacokinetic and preclinical safety studies of endolysin-based therapeutic for intravenous administration	13
Comparative efficacy and safety of systemic antifungal agents for candidemia: a systematic review with network meta-analysis and multicriteria acceptability analyses	13
In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam	13
Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials	13
Pharmacodynamic and immunomodulatory effects of polymyxin B in combination with fosfomycin against KPC-2-producing Klebsiella pneumoniae	13
How to combine novel techniques with stewardship: A real-world experience	12
Optimising culture results of orthopaedic infections using blood culture bottles	12
Two natural compounds as potential inhibitors against the Helicobacter pylori and Acinetobacter baumannii IspD enzymes	12
Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study	12
Genomic characterization of phenotypically carbapenem-resistant Escherichia coli isolates carrying unknown resistance genes in Malaysia	12
Pro) Piperacillin-tazobactam for ESBL-producing Enterobacterales	12
Persistence and dynamic structures of diverse cephalosporinase genes in nontyphoidal Salmonella in cross-sectional surveillance in Taiwan	12
The dlt operon contributes to the resistance to chlorhexidine in Streptococcus mutans	12
Long-term effects of ciprofloxacin treatment on the gastrointestinal and oropharyngeal microbiome are more pronounced after longer antibiotic courses	12
FL058, a novel β-lactamase inhibitor, increases the anti-Mycobacterium abscessus activity of imipenem	12
Con) Piperacillin-tazobactam for ESBL-producing Enterobacterales	12
New options for bloodstream infections caused by colistin‐ or ceftazidime/avibactam‐resistant Klebsiella pneumoniae	12
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: New data from CREDIBLE-CR with an updated meta-analysis	12
Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam	11
Access to phage therapy at Hospices Civils de Lyon in 2022: Implementation of the PHAGEinLYON Clinic programme	11
Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future	11
Susceptibility of Southeast Asian Plasmodium falciparum isolates to P218	11
Intravenous to oral antibiotics versus intravenous antibiotics: a step-up or a step-down for extended spectrum β-lactamase (ESBL)-producing urinary tract infections without concomitant bacteraemia?	11
Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the O	11
Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience	11
Reviewer Thank you List 2021	11
Sequential treatment effects on phage–antibiotic synergistic application against multi-drug-resistant Acinetobacter baumannii	11
A novel indolylbenzoquinone compound HL-J6 suppresses biofilm formation and α-toxin secretion in methicillin-resistant Staphylococcus aureus	11
In Vivo emergence of ceftazidime/avibactam, cefiderocol and aztreonam/avibactam cross-resistance in a patient with KPC-producing infection after cefiderocol-based treatment	11
Strategies for quorum sensing inhibition as a tool for controlling Pseudomonas aeruginosa infections	11
Impact of mass and systematic antibiotic administration on antibiotic resistance in low- and middle-income countries. A systematic review	11
The emergence of transposon-driven multidrug resistance in invasive nontypeable Haemophilus influenzae over the last decade	11
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	11
The antimicrobial activity of innate host-directed therapies: A systematic review	11
Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections	11
Title Page & Editorial Board	11
Letter to the Editor: Comment to “Assessment of Dientamoeba fragilis interhuman transmission by fecal microbiota transplantation” by Moreno-Sabater et al. (2025)	11
Multicentre Clinical Evaluation of a Molecular Diagnostic Assay to Identify Neisseria gonorrhoeae Infection and Detect Antimicrobial Resistance	11
Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns	11
Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltr	11
Plasma effects on bacterial time-kill dynamics: Insights from a PK/PD modelling analysis	11
IGRA-based INH regimen for prevention of active tuberculosis after kidney transplantation: A single-centre retrospective study	11
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity	10
Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics	10
Molecular typification of Escherichia coli from community-acquired urinary tract infections in Mexico	10
Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis	10
In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Dat	10
The evolution of carbapenem-resistant Pseudomonas aeruginosa in the COVID-19 era: A global perspective and regional insights	10
A 22-year Brazilian colistin resistance surveillance on Escherichia coli and Salmonella spp. originating from food-producing animals	10
Clinical features and outcomes of vancomycin-resistant enterococcal meningitis in neonatal intensive care unit patients: presentation of three cases	10
Head-to-head comparison of multi-dose oritavancin and dalbavancin for complicated infections: A propensity score-matched analysis	10
Delivery of endolysin across outer membrane of Gram-negative bacteria using translocation domain of botulinum neurotoxin	10
Evaluation of deoxythymidine-based cationic amphiphiles as antimicrobial, antibiofilm, and anti-inflammatory agents	10
In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020	10
Intestinal colonisation with hypervirulent or third-generation cephalosporin-resistant Klebsiella pneumoniae strains upon hospital admission in a general ward in Taiwan	10
Investigating an outbreak of extensively drug-resistant Acinetobacter baumannii in a tertiary healthcare centre in lebanon using next-generation sequencing	10
Title Page & Editorial Board	10
Candida parapsilosis isolates carrying mutations outside FKS1 hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance	10
Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeability	10
Trial Sequential Analysis of Intrathecal/Intraventricular Antimicrobial Therapy for Post-Neurosurgical Gram-Negative Bacillary Meningitis or Ventriculitis	10
The Trifecta of Diagnostic Stewardship, Antimicrobial Stewardship, and Value Assessment of New Diagnostic Tests	10
Role of tcaA, a potential target as a ceftobiprole resistance breaker in MRSA β-lactam resistance	10
In vitro activity of WCK 5222 (cefepime/zidebactam) against bioterror pathogen Burkholderia pseudomallei	10
Models for cytotoxicity screening of antileishmanial drugs: what has been done so far?	10
Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae	10
Anti-Porphyromonas gingivalis nanotherapy for maintaining bacterial homeostasis in periodontitis	10
Extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in humans and from food-producing animals in Italy: a ‘One Health’ study	10
Genetic alterations in methicillin-susceptible Staphylococcus aureus associated with high vancomycin minimum inhibitory concentration	10
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial	10
Unveiling the Clonal Dynamics and transmission mechanism of Carbapenem-Resistant Klebsiella pneumoniae in the ICU environment	10
The epidemiology and clinical spectrum of melioidosis in a tertiary hospital in a north-eastern state of Malaysia: A three-year review	10
Clinical and laboratory factors in predicting mortality among SARS-CoV-2 RNA positive patients from a tertiary care center in South Tamilnadu – A retrospective observational study	10
A translational rat model to assess glomerular function changes with vancomycin	10
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeabilit	10
Pattern and appropriateness of antibiotic prescriptions for upper respiratory tract infections in primary care paediatric patients	10
Systematic review of disulfiram as an antibacterial agent: what is the evidence?	9
Emergence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacterales in Spain studied by whole-genome sequencing	9
Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis	9
Identification of a multi-replicon plasmid co-harboring mcr-1 and tmexCD3-toprJ1 in Escherichia coli ST101 isolated from wastewater in South Korea	9
Blockade of pan-viral propagation by inhibition of host cell PNPT1	9
MtrAB two-component system is crucial for the intrinsic resistance and virulence of Mycobacterium abscessus	9
Phylogenetic insights of a human-derived optrA-positive Staphylococcus aureus isolated from a person with chronic diarrhea in China	9
In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in the Asia-Pacific region: SMART 2017-2020	9
Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia	9
Effect of achieving bone sterilisation on bone architecture and bone marrow, in an experimental rabbit model of osteomyelitis caused by carbapenemase-producing Enterobacterales	9
Controlling biofilm and virulence properties of Gram-positive bacteria by targeting wall teichoic acid and lipoteichoic acid	9
Whole-genome analysis of drug-resistant Mycobacterium tuberculosis reveals novel mutations associated with fluoroquinolone resistance	9
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections	9
Efficacy of piperacillin-tazobactam and cefotaxime against Escherichia coli hyperproducing TEM-1 in a mouse peritonitis infection model	9
A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjects	9
Small-molecule antiviral treatments for COVID-19: A systematic review and network meta-analysis	9
Investigation of PhoP response regulator inhibition to overcome resistance in Gram-negative clinical bacteria	9
Indocyanine green clearance test as a predictor of linezolid overexposure in septic patients	9
Colistin-EDTA combination for eradication of colistin-resistant Klebsiella pneumoniae catheter related biofilm infections	9